Effect of odanacatib on bone density and estimated bone strength in postmenopausal women: a CT-based sub-study of the phase 3 long-term odanacatib fracture trial (LOFT)

2016 ◽  
Author(s):  
Bente Langdahl ◽  
Villiers Tobias De ◽  
Tony M Keaveny ◽  
Klaus Engelke ◽  
Harry Genant ◽  
...  
Keyword(s):  
Bone Density ◽  
Postmenopausal Women ◽  
Bone Strength ◽  
Phase 3

Efficacy of odanacatib in postmenopausal women with osteoporosis: subgroup analyses of data from the phase 3 long-term odanacatib fracture trial (LOFT)

2016 ◽  
Author(s):  
Kenneth G Saag ◽  
Peter Alexandersen ◽  
Claude-Laurent Benhamou ◽  
Nigel Gilchrist ◽  
Johan Halse ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Phase 3 ◽  
Subgroup Analyses

Alendronate Increases Bone Density and Bone Strength at the Distal Radius in Postmenopausal Women

1999 ◽  
Vol 14 (8) ◽  
pp. 1387-1393 ◽  
Author(s):  
Peter F. Schneider ◽  
Manfred Fischer ◽  
Bruno Allolio ◽  
Dieter Felsenberg ◽  
Ulf Schröder ◽  
...  
Keyword(s):  
Bone Density ◽  
Postmenopausal Women ◽  
Bone Strength ◽  
Distal Radius

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

Bone ◽  
2008 ◽  
Vol 43 (2) ◽  
pp. 222-229 ◽  
Author(s):  
Paul D. Miller ◽  
Michael A. Bolognese ◽  
E. Michael Lewiecki ◽  
Michael R. McClung ◽  
Beiying Ding ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bone Density ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Phase 2 ◽  
Low Bone Mass ◽  
Phase 2 Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document